Midbrain KCC2 Downregulation: Implications for Stress-related and Substance Use Behaviors

Overview

Journal Curr Opin Neurobiol

Specialties Biology
Neurology

Date 2024 Aug 14

PMID 39142020

Authors

Anna C Pearson

Alexey Ostroumov

Affiliations

Soon will be listed here.

Abstract

Stress-related and substance use disorders are both characterized by disruptions in reward-related behaviors, and these disorders are often comorbid with one another. Recent investigations have identified a novel mechanism of inhibitory plasticity induced by both stress and substance use within the ventral tegmental area (VTA), a key region in reward processing. This mechanism involves the neuron-specific potassium chloride cotransporter isoform 2 (KCC2), which is essential in modulating inhibitory signaling through the regulation of intracellular chloride (Cl) in VTA GABA neurons. Experiences, such as exposure to stress or substance use, diminish KCC2 expression in VTA GABA neurons, leading to abnormal reward-related behaviors. Here, we review literature suggesting that KCC2 downregulation contributes to irregular dopamine (DA) transmission, impacting multiple reward circuits and promoting maladaptive behaviors. Activating KCC2 restores canonical GABA functioning and reduces behavioral deficits in preclinical models, leading us to advocate for KCC2 as a target for therapies aimed at alleviating and mitigating various stress-related and substance use disorders.

References

Moore Y, Deeb T, Chadchankar H, Brandon N, Moss S . Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures. Proc Natl Acad Sci U S A. 2018; 115(40):10166-10171. PMC: 6176565. DOI: 10.1073/pnas.1810134115. View

Wang G, Smith L, Volkow N, Telang F, Logan J, Tomasi D . Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry. 2011; 17(9):918-25. PMC: 3261322. DOI: 10.1038/mp.2011.86. View

Pan W, Brown J, Dudman J . Neural signals of extinction in the inhibitory microcircuit of the ventral midbrain. Nat Neurosci. 2012; 16(1):71-8. PMC: 3563090. DOI: 10.1038/nn.3283. View

Brown M, Tan K, OConnor E, Nikonenko I, Muller D, Luscher C . Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning. Nature. 2012; 492(7429):452-6. DOI: 10.1038/nature11657. View

Simonnet C, Sinha M, Goutierre M, Moutkine I, Daumas S, Poncer J . Silencing KCC2 in mouse dorsal hippocampus compromises spatial and contextual memory. Neuropsychopharmacology. 2022; 48(7):1067-1077. PMC: 10209115. DOI: 10.1038/s41386-022-01480-5. View

Al-Hasani R, Gowrishankar R, Schmitz G, Pedersen C, Marcus D, Shirley S . Ventral tegmental area GABAergic inhibition of cholinergic interneurons in the ventral nucleus accumbens shell promotes reward reinforcement. Nat Neurosci. 2021; 24(10):1414-1428. PMC: 8823543. DOI: 10.1038/s41593-021-00898-2. View

Shibasaki M, Masukawa D, Ishii K, Yamagishi Y, Mori T, Suzuki T . Involvement of the K+-Cl- co-transporter KCC2 in the sensitization to morphine-induced hyperlocomotion under chronic treatment with zolpidem in the mesolimbic system. J Neurochem. 2013; 125(5):747-55. DOI: 10.1111/jnc.12258. View

Taylor A, Becker S, Schweinhardt P, Cahill C . Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction. Pain. 2016; 157(6):1194-1198. PMC: 4866581. DOI: 10.1097/j.pain.0000000000000494. View

Niv Y, Daw N, Joel D, Dayan P . Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology (Berl). 2006; 191(3):507-20. DOI: 10.1007/s00213-006-0502-4. View

10.

Kutlu M, Zachry J, Melugin P, Tat J, Cajigas S, Isiktas A . Dopamine signaling in the nucleus accumbens core mediates latent inhibition. Nat Neurosci. 2022; 25(8):1071-1081. PMC: 9768922. DOI: 10.1038/s41593-022-01126-1. View

11.

Ostroumov A, Wittenberg R, Kimmey B, Taormina M, Holden W, McHugh A . Acute Nicotine Exposure Alters Ventral Tegmental Area Inhibitory Transmission and Promotes Diazepam Consumption. eNeuro. 2020; 7(2). PMC: 7082131. DOI: 10.1523/ENEURO.0348-19.2020. View

12.

Wise R, Robble M . Dopamine and Addiction. Annu Rev Psychol. 2020; 71:79-106. DOI: 10.1146/annurev-psych-010418-103337. View

13.

Deister C, Teagarden M, Wilson C, Paladini C . An intrinsic neuronal oscillator underlies dopaminergic neuron bursting. J Neurosci. 2009; 29(50):15888-97. PMC: 2824818. DOI: 10.1523/JNEUROSCI.4053-09.2009. View

14.

Payne J, Rivera C, Voipio J, Kaila K . Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci. 2003; 26(4):199-206. DOI: 10.1016/S0166-2236(03)00068-7. View

15.

Post M, Sulzer D . The chemical tools for imaging dopamine release. Cell Chem Biol. 2021; 28(6):748-764. PMC: 8532025. DOI: 10.1016/j.chembiol.2021.04.005. View

16.

Eshel N, Bukwich M, Rao V, Hemmelder V, Tian J, Uchida N . Arithmetic and local circuitry underlying dopamine prediction errors. Nature. 2015; 525(7568):243-6. PMC: 4567485. DOI: 10.1038/nature14855. View

17.

Ferrini F, Trang T, Mattioli T, Laffray S, Delguidice T, Lorenzo L . Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis. Nat Neurosci. 2013; 16(2):183-92. PMC: 4974077. DOI: 10.1038/nn.3295. View

18.

Zhou W, Kim K, Ali F, Pittenger S, Calarco C, Mineur Y . Activity of a direct VTA to ventral pallidum GABA pathway encodes unconditioned reward value and sustains motivation for reward. Sci Adv. 2022; 8(42):eabm5217. PMC: 9581470. DOI: 10.1126/sciadv.abm5217. View

19.

Ferrini F, Lorenzo L, Godin A, Le Quang M, De Koninck Y . Enhancing KCC2 function counteracts morphine-induced hyperalgesia. Sci Rep. 2017; 7(1):3870. PMC: 5478677. DOI: 10.1038/s41598-017-04209-3. View

20.

Taylor S, Badurek S, DiLeone R, Nashmi R, Minichiello L, Picciotto M . GABAergic and glutamatergic efferents of the mouse ventral tegmental area. J Comp Neurol. 2014; 522(14):3308-34. PMC: 4107038. DOI: 10.1002/cne.23603. View